← Leaderboards
Deborah Lannigan-Macara
University Of Virginia Charlottesville
$4,630,198
Attributed
$5,826,918
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $916K · FY2008–22$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,826,918 · 7
By mechanism
R01$4,794,225 · 3
R21$684,240 · 2
S10$199,617 · 1
R41$148,836 · 1
Top collaborators
- Gary Allen Sulikowski5 shared
- Alex G Waterson5 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Mary E Ropka$905,317
Others in their field
Top investigators on “Protein Kinase”
- David Heimbrook · Leidos Biomedical Research, Inc.$63,024,346
- Asrar B. Malik · University Of Illinois At Chicago$42,318,340
- John Blenis · Harvard University (Medical School)$31,872,790
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$25,670,024
- Michael H Nathanson · Yale University$25,355,113
- Joel S Greenberger · University Of Pittsburgh At Pittsburgh$24,937,005
Research focus
Protein KinaseCellsMalignant NeoplasmsBaseComplexIn VitroNuclearMutantCell NucleusRegulationMediatingResponseMalignant Breast NeoplasmPhysiologicalPreventLongitudinal AnalysisPathway InteractionsStatisticsCytoplasmAutomobile DrivingIn VivoSignal TransductionLinkProteins
Grant awards (21)
Estrogen Receptor Homeostasis$393,956
R01 · FY2022 · DK · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$352,773
R01 · FY2022 · CA · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$359,982
R01 · FY2021 · CA · contact PI
Estrogen Receptor Homeostasis$393,956
R01 · FY2020 · DK · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$359,985
R01 · FY2020 · CA · contact PI
Estrogen Receptor Homeostasis$393,956
R01 · FY2019 · DK · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$349,083
R01 · FY2019 · CA · contact PI
Estrogen Receptor Homeostasis$393,956
R01 · FY2018 · DK · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$373,257
R01 · FY2018 · CA · contact PI
Targeting the host response to limit infection by intracellular bacterial pathogens$148,836
R41 · FY2018 · AI · contact PI
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection$137,120
R21 · FY2017 · CA · contact PI
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection$251,120
R21 · FY2016 · CA · contact PI
XFe96 Analyzer$199,617
S10 · FY2014 · OD · contact PI
Cellular Responses to Stress$244,185
R01 · FY2012 · GM · contact PI
Cellular Responses to Stress$235,208
R01 · FY2011 · GM · contact PI
Cellular Responses to Stress$237,584
R01 · FY2010 · GM · contact PI
Cellular Responses to Stress$239,984
R01 · FY2009 · GM · contact PI
Cellular Responses to Stress$226,376
R01 · FY2009 · GM · contact PI
Cellular Responses to Stress$239,984
R01 · FY2008 · GM · contact PI
Identification of inhibitors for the Rsk2 protein kinase$148,000
R21 · FY2003 · CA
Identification of inhibitors for the Rsk2 protein kinase$148,000
R21 · FY2002 · CA